We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
-16.28%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$873M
AUM Growth
-$318M
Cap. Flow
+$117M
Cap. Flow %
13.43%
Top 10 Hldgs %
72.8%
Holding
33
New
2
Increased
20
Reduced
9
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 29.08%
2 Communication Services 20.02%
3 Consumer Staples 12.39%
4 Healthcare 12.25%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$120M 13.76%
1,101,820
+27,260
+3% +$3.21M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$116M 13.35%
426,694
+365,649
+599% +$115M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$78.5B
$88.2M 10.11%
149,189
+10,172
+7% +$6.61M
HLF icon
4
Herbalife
HLF
$1.29B
$61.3M 7.02%
2,996,661
+34,026
+1% +$841K
V icon
5
Visa
V
$684B
$58.3M 6.68%
295,928
+136,084
+85% +$28.1M
IBKR icon
6
Interactive Brokers
IBKR
$39.2B
$48.9M 5.6%
3,553,312
+415,488
+13% +$6.17M
CTVA icon
7
Corteva
CTVA
$52.6B
$48.7M 5.59%
900,196
+5,369
+0.6% +$312K
IBB icon
8
iShares Biotechnology ETF
IBB
$9.34B
$33.4M 3.83%
+284,269
New +$33.7M
ATVI
9
DELISTED
Activision Blizzard
ATVI
$32M 3.67%
410,805
+2,120
+0.5% +$165K
IWO icon
10
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
$27.9M 3.19%
135,000
-415,200
-75% -$92.6M
PINS icon
11
Pinterest
PINS
$13.4B
$26.3M 3.01%
1,448,160
+114,734
+9% +$2.4M
PM icon
12
Philip Morris
PM
$297B
$20.2M 2.31%
204,440
+50,855
+33% +$5.18M
GHC icon
13
Graham Holdings Company
GHC
$5.1B
$18.3M 2.1%
32,268
+1,488
+5% +$885K
HIBB
14
DELISTED
Hibbett, Inc. Common Stock
HIBB
$16.6M 1.9%
379,019
+223,494
+144% +$10.3M
META icon
15
Meta Platforms (Facebook)
META
$1.42T
$16.4M 1.88%
101,625
+56,292
+124% +$10.9M
IWM icon
16
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$15.9M 1.83%
94,100
-65,300
-41% -$12M
STT icon
17
State Street
STT
$50.6B
$15.2M 1.74%
246,646
-8,584
-3% -$607K
BNY
18
Bank of New York Mellon
BNY
$106B
$14.9M 1.71%
357,760
+344,969
+2,697% +$15.4M
SQM icon
19
Sociedad Química y Minera de Chile
SQM
$19.2B
$14M 1.6%
167,185
+7,341
+5% +$646K
SHC icon
20
Sotera Health
SHC
$5.09B
$13.6M 1.55%
691,739
-92,896
-12% -$1.95M
GIS icon
21
General Mills
GIS
$19.1B
$12.4M 1.43%
164,939
-14,931
-8% -$1.05M
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.36T
$11.9M 1.36%
108,880
-9,500
-8% -$1.12M
ALB icon
23
Albemarle
ALB
$13.9B
$11.5M 1.31%
+54,810
New +$12.2M
MO icon
24
Altria Group
MO
$114B
$9.54M 1.09%
228,395
-57,032
-20% -$2.95M
MDLZ icon
25
Mondelez International
MDLZ
$79.5B
$4.66M 0.53%
75,107
-22,830
-23% -$1.44M

Similar funds

Bronte Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bronte Capital Management held 33 positions worth $873M, down 27% from $1.19B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bronte Capital Management deployed $117M of net new capital in Q2 2022, opening 2 new positions and adding to 20 existing holdings. Its largest new stake was iShares Biotechnology ETF: 284,269 shares worth $33.4M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 7.7% a quarter earlier, followed by Communication Services and Consumer Staples.

On the sell side, the largest reduction was Bath & Body Works, an estimated $11.5M trimmed.

  • Bronte Capital Management's largest Q2 2022 buy was iShares Biotechnology ETF: 284,269 shares worth $33.4M.
  • Bronte Capital Management added most to Berkshire Hathaway Class B in Q2 2022, an estimated $115M increase.
  • Bronte Capital Management's biggest Q2 2022 reduction was Bath & Body Works, cutting an estimated $11.5M.
  • Bronte Capital Management's ten largest holdings make up 73% of its $873M portfolio in Q2 2022.
  • Bronte Capital Management opened 2 new positions and closed 1 in Q2 2022.
  • Bronte Capital Management's portfolio value fell 27% quarter-over-quarter to $873M.

Based on Bronte Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.